These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31509353)

  • 1. Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists.
    McNamara DM; Goldberg SL; Latts L; Atieh Graham DM; Waintraub SE; Norden AD; Landstrom C; Pecora AL; Hervey J; Schultz EV; Wang CK; Jungbluth N; Francis PM; Snowdon JL
    Cancer Med; 2019 Nov; 8(15):6578-6584. PubMed ID: 31509353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.
    Zhou N; Zhang CT; Lv HY; Hao CX; Li TJ; Zhu JJ; Zhu H; Jiang M; Liu KW; Hou HL; Liu D; Li AQ; Zhang GQ; Tian ZB; Zhang XC
    Oncologist; 2019 Jun; 24(6):812-819. PubMed ID: 30181315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board.
    Somashekhar SP; Sepúlveda MJ; Puglielli S; Norden AD; Shortliffe EH; Rohit Kumar C; Rauthan A; Arun Kumar N; Patil P; Rhee K; Ramya Y
    Ann Oncol; 2018 Feb; 29(2):418-423. PubMed ID: 29324970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non-small cell lung cancer patients at a lung cancer center in China.
    Yao S; Wang R; Qian K; Zhang Y
    Thorac Cancer; 2020 May; 11(5):1265-1270. PubMed ID: 32191394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Concordance With Watson for Oncology, a Cognitive Computing Decision Support System for Colon Cancer Treatment in Korea.
    Lee WS; Ahn SM; Chung JW; Kim KO; Kwon KA; Kim Y; Sym S; Shin D; Park I; Lee U; Baek JH
    JCO Clin Cancer Inform; 2018 Dec; 2():1-8. PubMed ID: 30652564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance Between Watson for Oncology and a Multidisciplinary Clinical Decision-Making Team for Gastric Cancer and the Prognostic Implications: Retrospective Study.
    Tian Y; Liu X; Wang Z; Cao S; Liu Z; Ji Q; Li Z; Sun Y; Zhou X; Wang D; Zhou Y
    J Med Internet Res; 2020 Feb; 22(2):e14122. PubMed ID: 32130123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China.
    Zhao X; Zhang Y; Ma X; Chen Y; Xi J; Yin X; Kang H; Guan H; Dai Z; Liu D; Zhao F; Sun C; Li Z; Zhang S
    Jpn J Clin Oncol; 2020 Aug; 50(8):852-858. PubMed ID: 32419014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance Study Between IBM Watson for Oncology and Real Clinical Practice for Cervical Cancer Patients in China: A Retrospective Analysis.
    Zou FW; Tang YF; Liu CY; Ma JA; Hu CH
    Front Genet; 2020; 11():200. PubMed ID: 32265980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence Treatment Decision Support For Complex Breast Cancer Among Oncologists With Varying Expertise.
    Xu F; Sepúlveda MJ; Jiang Z; Wang H; Li J; Yin Y; Liu Z; Roebuck MC; Shortliffe EH; Yan M; Song Y; Geng C; Tang J; Rhee K
    JCO Clin Cancer Inform; 2019 Aug; 3():1-15. PubMed ID: 31419181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience.
    Pan H; Tao J; Qian M; Zhou W; Qian Y; Xie H; Jing S; Xu T; Zhang X; Dai Z; You M; Liu Y; Liu X; Wang S
    Transl Cancer Res; 2019 Apr; 8(2):389-401. PubMed ID: 35116771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence in Decision-Making for Colorectal Cancer Treatment Strategy: An Observational Study of Implementing Watson for Oncology in a 250-Case Cohort.
    Aikemu B; Xue P; Hong H; Jia H; Wang C; Li S; Huang L; Ding X; Zhang H; Cai G; Lu A; Xie L; Li H; Zheng M; Sun J
    Front Oncol; 2020; 10():594182. PubMed ID: 33628729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early experience with Watson for oncology in Korean patients with colorectal cancer.
    Kim EJ; Woo HS; Cho JH; Sym SJ; Baek JH; Lee WS; Kwon KA; Kim KO; Chung JW; Park DK; Kim YJ
    PLoS One; 2019; 14(3):e0213640. PubMed ID: 30908530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of an oncology clinical decision-support system's recommendations with actual treatment decisions.
    Suwanvecho S; Suwanrusme H; Jirakulaporn T; Issarachai S; Taechakraichana N; Lungchukiet P; Decha W; Boonpakdee W; Thanakarn N; Wongrattananon P; Preininger AM; Solomon M; Wang S; Hekmat R; Dankwa-Mullan I; Shortliffe E; Patel VL; Arriaga Y; Jackson GP; Kiatikajornthada N
    J Am Med Inform Assoc; 2021 Mar; 28(4):832-838. PubMed ID: 33517389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early experience with Watson for Oncology: a clinical decision-support system for prostate cancer treatment recommendations.
    Yu SH; Kim MS; Chung HS; Hwang EC; Jung SI; Kang TW; Kwon D
    World J Urol; 2021 Feb; 39(2):407-413. PubMed ID: 32335733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea.
    Choi YI; Chung JW; Kim KO; Kwon KA; Kim YJ; Park DK; Ahn SM; Park SH; Sym SJ; Shin DB; Kim YS; Sung KH; Baek JH; Lee U
    Can J Gastroenterol Hepatol; 2019; 2019():8072928. PubMed ID: 30854352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility Study.
    Liu C; Liu X; Wu F; Xie M; Feng Y; Hu C
    J Med Internet Res; 2018 Sep; 20(9):e11087. PubMed ID: 30257820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care.
    Simon G; DiNardo CD; Takahashi K; Cascone T; Powers C; Stevens R; Allen J; Antonoff MB; Gomez D; Keane P; Suarez Saiz F; Nguyen Q; Roarty E; Pierce S; Zhang J; Hardeman Barnhill E; Lakhani K; Shaw K; Smith B; Swisher S; High R; Futreal PA; Heymach J; Chin L
    Oncologist; 2019 Jun; 24(6):772-782. PubMed ID: 30446581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of real-world evidence for oncology clinical decision making in emerging economies.
    Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M
    Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
    Kim M; Kim BH; Kim JM; Kim EH; Kim K; Pak K; Jeon YK; Kim SS; Park H; Kang T; Lee BJ; Kim IJ
    Cancer; 2019 Aug; 125(16):2803-2809. PubMed ID: 31216369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.